Synovics Pharma Revenue, Profits - SYVC Annual Income Statement

Add to My Stocks
$0 $0 (0%) SYVC stock closing price Jun 08, 2018 (Closing)

Looking at financial statements, along with the Synovics Pharma stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. Like any other income statement, the SYVC income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a YOY revenue growth of 0 when compared to the same period in the past. One also needs to look at Synovics Pharma assets, operating expenses and Synovics Pharma free cash flow. The Synovics Pharma profit and loss statement shows revenue of $25.95M for 2008. Revenue has grown by 0 YOY for SYVC stock.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Nov - Oct2008
Synovics Pharma Revenues or Net Sales
25.95M
Cost Of Goods Sold (COGS)16.98M
Synovics Pharma Gross Profit
8.97M
Research & Development Expense1.17M
Selling General & Admin Expense10.27M
Income Before Depreciation Depletion Amortization-2.48M
Depreciation Depletion Amortization-
Non Operating Income2.64M
Interest Expense4.16M
Synovics Pharma Pretax Income
-4M
Provision for Income Taxes-
MinorityInterest-
Investment Gains Losses-
Other Income-
Income Before Extraordinaries & Disc Operations-4M
Extraordinary Items & Discontinued Operations-
Synovics Pharma Profit/ Loss (Net Income)
-4M
Average Shares used to compute Diluted EPS23.55M
Average Shares used to compute Basic EPS23.55M
Income Before Nonrecurring Items-6.65M
Income from Nonrecurring Items2.64M
Synovics Pharma Earnings Per Share Basic Net
-0.17
Synovics Pharma Earnings Per Share Diluted Net
-0.17
EPS Diluted Before Nonrecurring Items-0.28
Preferred Dividends Acc Pd-
Dividends Common-
Dividend Per Share Common0.00
All figures in USD. M: Millions of USD, B: Billions of USD.

Before investing one should read a report on Synovics Pharma stock analysis. It helps to look at the following income statement items:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: Synovics Pharma revenue chart implies that the company is growing. It has been the case with Synovics Pharma. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-4M for SYVC stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the SYVC income statement, one can check the Synovics Pharma historical stock prices to check how the price has moved with time.